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Colonic anastomotic leakage is still a problem in general surgery practice. We sought to
investigate the effect of a new tissue adhesive, BioGlue, on the healing of normal and
impaired colonic anastomoses. Sixty-four rats were randomized into 4 groups. In all
animals, a 1-cm segment of the left colon was resected, and an end-to-end sutured
anastomosis was created. Animals were then divided into 2 groups: normal and impaired
anastomosis. These 2 groups were further subdivided into 2 additional groups: animals
that received BioGlue and those that did not. All rats received intraperitoneal injections
of either 0.9% NaCl or 5-fluorouracil (5-FU). Anastomotic evaluation was done 7 days
after surgery. Macroscopic healing, mechanical strength, and histopathologic healing
parameters were evaluated. Leakage of the anastomosis was significantly higher in rats in
the impaired group compared with those in the BioGlue groups (P¼0.043). The adhesion
formation score was significantly higher in rats in the impaired anastomosis group
compared with the other groups. Bursting pressures were significantly lower in the
impaired anastomosis group than in the other ones (P ¼ 0.001). Neoangiogenesis and
fibroblast activity were different among the groups (P ¼ 0.001). Inflammatory cell
infiltration and collagen deposition did not differ among the groups (P ¼ 0.07).
Immediate postoperative intraperitoneal administration of 5-FU after colonic anastomo-
sis inhibits intestinal wound healing. Covering colon anastomoses with BioGlue after
suturing conferred beneficial effect on healing.
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Colonic resection and anastomoses are amongthe most frequently performed procedures in
general surgery. Anastomotic dehiscence and sub-
sequent leakage remain significant complications
that can lead to death, sepsis, and the need for more
surgery and a stoma.1–3 Moreover, there are several
short- and long-term sequelae associated with
anastomotic dehiscence and leakage including im-
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paired bowel function, anastomotic strictures, and
decreased survival rates in patients with cancer.4
It is well known that administering antineoplastic
drugs such as 5-fluorouracil (5-FU) immediately
after surgery can adversely affect the healing
process of colonic anastomoses.5–7 Several tech-
niques and devices, such as hand-sutured anasto-
moses and stapling devices, have been successfully
used to make colonic anastomoses. Other experi-
mental techniques that have been investigated for
bowel anastomoses include sutureless biofragment-
able rings, laser welding, and tissue adhesives. All
of these techniques are designed to be safe and easy,
even in the presence of impaired anastomosis
healing.8–10
BioGlue (CryoLife International Inc, Kennesaw,
Georgia) is a new bioadhesive that has been
experimentally tested in vitro and in vivo.11–14 It is
commonly used in vascular, cardiopulmonary, uro-
logic, and neurosurgical procedures.15–19
In this study, we investigate the effect of BioGlue
on healing anastomosis of the colon in a rat model of
experimentally impaired and normal colon anasto-
moses. To the best of our knowledge, this is the first
study to evaluate the effects of this new adhesive in
the healing of impaired anastomoses of the colon.
Materials and Methods
The Research Board and Ethics Committee of
Baskent University approved the study protocol.
Sixty-four male Wistar albino rats weighing 260 to
350 g were used. The animals were acclimatized to
their new surroundings for 1 week before the
procedures. They were housed under 12-hour
light-dark cycles in cages with no more than 3
animals per cage. They were fed standard rat chow
and had access to food and water ad libitum.
The animals were separated into 4 groups: In the
normal anastomosis group (Control), just a colonic
resection and anastomosis were performed on the
descending colon. In the normal anastomosis Bio-
Glue group (Bio), BioGlue was applied to the
anastomosis site after a colonic resection and
anastomosis. The other 2 animal groups were
treated similarly except for the creation of impaired
anastomoses. These 2 groups were called the
impaired anastomosis group (IM) and the impaired
anastomosis plus BioGlue group (IM-Bio). All the
animals were killed 7 days after surgery to
investigate the healing of the anastomoses.
Anastomotic technique
Animals were anesthetized with a combination of 5
mg/kg xylazine (Rompun, Bayer, Istanbul, Turkey)
and 30 mg/kg ketamine hydrochloride (Ketalar,
Parke-Davis, Istanbul, Turkey) administered intra-
peritoneally. Sterile instruments were used for
surgery. After a 4-cm midline incision, the left colon
was mobilized and a 5-mm segment of the colon
was resected. The free ends of the colon were then
anastomosed using interrupted, inverting 7-0 poly-
propylene sutures (Prolene, Ethicon, Kirkton, Scot-
land) 1 mm apart. In all the animals, after suturing
the anastomosis, the fascia and the skin were closed
separately with three 3-0 silk (Mersilk, Ethicon)
sutures. All the operations were performed by the
same surgeon.
After closing the midline incision, animals in the
IM group received intraperitoneal 5-FU. From the
day of the operation until the day they were killed,
the animals in groups Control (C) and Bio received
intraperitoneal injections of 3 mL normal saline once
daily. The animals in the IM and IM-Bio groups
received intraperitoneal injections of 5-FU at a
dosage of 20 mg/kg body weight from the day of
the operation until the day they were killed.
Application of BioGlue
The BioGlue was prepared according to the manu-
facturer’s directions. The BioGlue was applied to the
suture line using the supplied rigid applicator tip,
minimizing the exposure of the colon surface to the
BioGlue. Before applying the glue, all tissues in the
abdomen were protected with wet gauze. To ensure
the circumferential application of the tissue adhe-
sive, the colon was first rotated 908 counterclockwise
and then 908 clockwise for posterior application.
According to the manufacturer’s instructions, to
protect the tissue from the toxic effects of the
BioGlue, the initial triggered material must be
discarded because of the likelihood of increased
glutaraldehyde release.
Assessment of anastomosis
To assess the anastomoses, the animals in all groups
were killed 7 days after surgery. For gross assessment,
after relaparotomy, the abdomen and the anastomoses
were evaluated for abscess and adhesion formation.
Peritonitis was recorded as present or absent.
Adhesion formation was recorded in a blind
manner according to the scale of van der Ham et al
as follows: 0, no adhesions; 1, minimal adhesions
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(i.e., mainly between the omentum and the anasto-
motic site); 2, moderate adhesions (i.e., between the
omentum and the anastomotic site and between the
site and a loop of small bowel or abdominal wall);
and 3, severe and extensive adhesions (i.e., between
the anastomotic site and several loops of small
bowel and the abdominal wall).20 Abscess formation
was recorded as present or absent.
Intestinal obstruction was recorded as being
present when the diameter of the segment proximal
to the anastomosis was 2 times the diameter of the
segment distal to the anastomosis. A 4-cm segment
of the colon including the anastomosis at the
midportion was gently dissected free of the sur-
rounding tissues. The tissues that adhered to the
anastomosis too tightly were not pushed away. The
lumen of the colon was cleaned of the fecal content
by gentle flushing with saline and not pushed away.
To assess the mechanical strength of the anasto-
mosis, a suture was placed to close 1 end of the
excised segment. The free end of the colon was then
catheterized with a polyurethane tube (2-mm outer
diameter), and a stay suture was tied over to
prevent the leakage of air. The other end of the
catheter was connected to an infusion pump and to
a mercury manometer through a Y tube. The colon
segment was then placed in a container filled with
normal saline, and air was pumped through at a rate
of 5 mL/min. The reading at which the pressure
declined suddenly or at which bubbles were seen
was recorded as the bursting pressure. After
measuring the bursting pressure, the colon segment
was divided along its long axis. A 5-mm ring of
tissue including the anastomosis was excised and
was stored in 10% formaldehyde for later assess-
ment of the histopathologic features.
For histopathologic assessment, the tissues that
had been fixed in 10% formaldehyde were stained
with hematoxylin and eosin and were evaluated at
320 to 3200 magnification under the light micro-
scope. The anastomoses were graded histologically
in a blind fashion, using the 0 to 4 Ehrlich and Hunt
numeric scale as modified by Reddy et al21 and
Phillips et al.22 Inflammatory cell infiltration (white
blood cell count), fibroblast activity, blood vessel
neodevelopment (neoangiogenesis), and collagen
deposition were graded from 0 to 4 as follows: 0 ¼
no evidence, 1 ¼ occasional evidence, 2 ¼ light
scattering, 3¼ abundant evidence, and 4¼ confluent
cells or fibers.
Statistical analysis
The results were analyzed by the v2 test and
Kruskal-Wallis test, whereas pairwise differences
were compared using the Mann-Whitney U test. A P
value of less than 0.05 was accepted as statistically
significant.
Results
All animals recovered from surgery. They were
killed at a designated time, and there were no
deaths during the experiment. One rat from the
control group (6%) and 5 rats (31%) from the IM
group developed anastomotic dehiscence. The leak-
age rates of the anastomosis differed significantly
among the groups (Table 1). The dehiscence rate was
significantly higher in the IM group compared with
the Bio and IM-Bio groups, in which no dehiscence
was observed (P¼ 0.043 for both comparisons). The
differences between the C group and no-dehiscence
group were not statistically significant. Seven days
after the surgery, a wound infection developed in 1
rat in the IM group, 1 rat in the IM-Bio group, and 1
rat in the Bio group (P ¼ 0.496). Intra-abdominal
abscess was detected in 2 rats in the IM group (P ¼
0.103).
The adhesion formation score was higher in the
IM group (2.3) compared with the other groups (P¼
0.014). The difference was not statistically significant
among the other groups.
The mean 6 SD bursting pressure values of
groups C, IM, Bio, and IM-Bio were 154.5 6 17.9,
85.8 6 22.9, 233.1 6 13, and 226.4 6 15.4 (P¼ 0.001;
Fig. 1), respectively. The bursting pressures of the
colons in rats with anastomotic dehiscence were not
added to the statistical calculation. The calculations
for groups C and IM were done using the remaining
15 and 11 bursting pressure values, respectively.
After a pairwise comparison using the Mann-
Whitney U test, the mean colonic bursting pressure
was found to be significantly lower in the IM group
than in the other groups. Specifically, the bursting
pressures were similar in the Bio and IM-Bio groups
Table 1 Dehiscence of anastomose
Group Number Dehiscence Percentage
C 16 1 6.2
IM 16 5 31.2
Bio 16 0 0
IM-Bio 16 0 0
Bio, anastomose þ BioGlue; C, normal anastomose; IM,
anastomose þ 5-fluorouracil; IM-Bio, anastomose þ 5-
fluorouracil þ BioGlue.
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(P ¼ 0.7). Control group bursting pressure was
significantly different than Bio groups (P ¼ 0.001;
Fig. 1).
The wound healing process was evaluated by
neoangiogenesis, fibroblast activity, inflammatory cell
infiltration, and collagen deposition scores (Fig. 2).
Neoangiogenesis and fibroblast activity scores
were different among the groups (C: 1.6–2; IM: 1.3–
1.6; Bio: 2–2.1; and IM-Bio: 2–2.1; respectively). The
Bio and IM-Bio groups had markedly high angio-
genesis and fibroblast activity compared with the
other groups. Inflammatory cell infiltration and
collagen deposition scores did not represent any
significant difference among the groups (compari-
son of the groups P¼ 0.2 and P¼ 0.4, respectively).
Discussion
Leakage of colonic anastomoses is a potentially
devastating surgical complication. Several factors
including bowel preparation before surgery, surgical
technique, nutritional status, and intervening patho-
logical conditions have been identified as significant
factors influencing the healing of colonic anastomo-
ses. The prevalence of anastomotic leakage varies
from 1% to 39%, but clinically significant leaks occur
more accurately in 3% to 6% of patients depending
on the definition and the type of the resection
performed.23 Anastomotic leakage may lead to
increased morbidity, mortality, prolonged hospital
stay, and extra cost. For these reasons, several types
of glue have been used to secure an anastomosis.
BioGlue surgical adhesive is a mixture of purified
bovine serum albumin (45%) and glutaraldehyde
(10%) that is commonly used in vascular and
cardiopulmonary repair surgery, tissue adherence,
and strengthening16 It is easy to prepare and apply
and begins to bond within 20 to 30 seconds,
reaching its maximum bonding capability in 2 to 3
minutes.16
It is well known that antimetabolites such as 5-FU
impair colonic healing by reducing local accumula-
tion of leucocytes, macrophages, and fibroblasts.
Decreased leucocytes in the wound with reduced
production of local cytokines and growth factors
may lead to anastomotic failure. 5-FU administered
immediately after an operation also has a negative
impact on fibroblast proliferation and collagen
synthesis, which can result in anastomotic leakage,
decreased mechanical strength, and delayed anas-
tomotic healing. According to the literature, the vast
majority of previous studies have shown that the
healing of colonic anastomosis has been impaired by
the immediate postoperative intraperitoneal admin-
istration of 5-FU.24–26 The dosage of 5-FU used in
our study, which is based on the results of similar
experimental studies,24 has been shown to retard the
healing of colon anastomosis.
Fig. 1 Bursting pressure measurements of the anastomosis. C,
normal anastomose; IM, anastomoseþ 5-fluorouracil; Bio,
anastomoseþ BioGlue; IM-Bio, anastomoseþ 5-fluorouracil þ
Bioglue.
Fig. 2 Histologic evaluation of groups. C, normal anastomose;
IM, anastomoseþ 5-fluorouracil; Bio, anastomoseþ BioGlue; IM-
Bio, anastomoseþ 5-fluorouracil þ Bioglue.
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The current study was in accordance with
previous studies; we too found that early postoper-
ative intraperitoneal 5-FU administration impaired
the healing of colon anastomosis. Specifically, in the
IM group, the anastomotic dehiscence rate was
31.5% and was significantly increased compared
with the other groups. In addition, our study
showed that covering the colon anastomoses with
BioGlue after suturing prevented the anastomosis
from leaking. Using BioGlue after suturing the
anastomoses creates a physical barrier preventing
the anastomosis from leaking during the early
postoperative period.
Because the anastomoses leaked in the IM group,
adhesion formation in this group also increased
compared with the other ones. This finding has been
observed in previous studies as well.5,7 Intraperito-
neal 5-FU administration changes the balance of the
fibrinolytic system, which is one of the basic factors
affecting the formation of peritoneal adhesions.27 In
addition, intra-abdominal infection causes abdomi-
nal inflammation, peritoneal damage, and disrupts
fibrinolysis resulting in abdominal adhesions.28–30
This study demonstrates that covering colon anas-
tomoses with BioGlue prevents anastomosis leak-
age; however, BioGlue does not have a significant
effect on adhesion formation.
To evaluate the strength of colon anastomoses in
the early wound healing period, we measured the
bursting pressures. The bursting pressures of the
anastomoses in the rats of the IM group were
significantly lower than those in the other groups.
Furthermore, applying BioGlue to a normal anasto-
mosis increased the anastomotic bursting pressure. It
seems that covering the anastomosis with BioGlue
prevented anastomotic dehiscence and strengthened
it. There was no clear evidence about the toxic effect of
glutaraldehyde contained in the glue on anastomoses.
Inflammation plays an important role in the
wound healing process. This process was assessed
by neoangiogenesis, fibroblast proliferation, inflam-
matory cell infiltration, and collagen deposition. In
this study, histologic evaluation of the colonic
anastomoses showed a marked failure in healing
in the IM group compared with the other groups as
demonstrated by the fact that neoangiogenesis and
fibroblast proliferation were significantly retarded.
Formaldehyde used in high concentrations (37%) in
the gelatin-resorcinol-formaldehyde glue seems to
have a toxic effect on the vascular wall.31,32 BioGlue
is a surgical adhesive that contains only 10%
glutaraldehyde. The results of various investigations
have shown the toxic potential of BioGlue on
different tissue types.33–36 The toxic effect of the
BioGlue on phrenic nerve and on cardiac conduc-
tion tissues has been reported.37 The toxicity of
BioGlue increases when the glue is in contact with
incisional tissue surfaces, especially those of the
lung and the liver; however, this effect decreases
when the glue is administered to the outer layer and
vascular tissues. The structure of vascular tissue is
different from that of lung and liver tissues.13 The
glue is used for tissue apposition and may be used
superficially rather than for primary closure. Long-
term follow-up of the glue’s use in aortic tissues has
shown that it causes severe active inflammation and
massive foreign body reaction.38
No long-term follow-up data on the effect of
BioGlue on colonic tissues are available. No foreign
body giant cells or glaucomatous tissues were found
in our study during early healing of the wound. In
the late phase of healing, however, it may be
detrimental, probably due to the ongoing inflam-
matory reaction.
In conclusion, early postoperative intraperitoneal
administration of 5-FU retards the healing of colon
anastomoses. Covering anastomoses with BioGlue
prevents the anastomoses from leaking and the
adverse effects of 5-FU. BioGlue is advantageous in
the experimentally normal and impaired colonic
anastomoses according to this study. Further inves-
tigations are needed to evaluate the early and late
effects of BioGlue on colonic anastomotic healing in
experimental settings and in clinical practice.
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